Most Undervalued Biotechnology Stocks 2026

Top undervalued Biotechnology stocks in 2026 ranked by Bayesian DCF implied upside. 13-model institutional analysis updated daily.

377 stocks analyzed Updated 2026-05-29
# Ticker Company QOC Price DCF Upside
1 MRVI Maravai LifeSciences Holdings, 6.4 $4.64 +238.0%
2 AGEN Agenus Inc. 4.8 $3.40 +230.8%
3 HRMY Harmony Biosciences Holdings, I 10.0 $31.49 +210.5%
4 MRNA Moderna, Inc. 7.1 $47.57 +175.4%
5 BYSI BeyondSpring, Inc. 3.5 $1.72 +152.2%
6 ORMP Oramed Pharmaceuticals Inc. 7.1 $3.96 +121.4%
7 MDXG MiMedx Group, Inc 8.6 $3.67 +88.1%
8 XLO Xilio Therapeutics, Inc. 5.2 $8.52 +83.0%
9 FBIO Fortress Biotech, Inc. 5.9 $2.81 +73.4%
10 JAZZ Jazz Pharmaceuticals plc 7.5 $235.38 +69.9%
11 C••• Compugen ••••• •.• $•••.•• ••.•%
12 I••• Innoviva, ••••• •.• $•••.•• ••.•%
13 B••• Bicycle ••••• •.• $•••.•• ••.•%
14 I••• ImageneBio, ••••• •.• $•••.•• ••.•%
15 A••• Abeona ••••• •.• $•••.•• ••.•%
16 P••• PureTech ••••• •.• $•••.•• ••.•%
17 H••• Halozyme ••••• •.• $•••.•• ••.•%
18 G••• Genmab ••••• •.• $•••.•• ••.•%
19 A••• ACADIA ••••• •.• $•••.•• ••.•%
20 R••• Royalty ••••• •.• $•••.•• ••.•%
🔒

Unlock the Full Most Undervalued Biotechnology Stocks 2026 List

Screen all 377 Biotechnology stocks with 13 institutional-grade valuation models. Updated daily from SEC EDGAR filings.

Access Full Screening — From $27/mo →

How CirclFi Ranks Biotechnology Stocks

CirclFi analyzes 377 Biotechnology stocks daily using 13 independent institutional-grade valuation models. Each model processes SEC EDGAR 10-K and 10-Q financial filings (700+ XBRL tags), FRED macroeconomic data, and GDELT news sentiment.

The most undervalued biotechnology stocks 2026 ranking uses dcf upside as the primary sort criterion. Models span intrinsic valuation (Bayesian DCF with 10,000 Monte Carlo simulations, EPV), scenario analysis (First Chicago), regime-switching (Markov DDM), and machine learning (ML-RIV, FTNN Topology).